Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
It is a randomized phase II study to determine the efficacy and safety of particle therapy
with or without apatinib as induction therapy for the treatment of head and neck adenoid
cystic carcinoma. Participants will be randomized to arm 1: receiving apatinib for 6 weekly
followed by particle radiotherapy; arm 2: particle radiotherapy alone.